(MedPage Today) — Patients taking GLP-1 agonists for weight loss had a small but significantly lower risk of developing cancer, a large retrospective cohort study showed.
With follow-up ranging from 1 to 11 years, use of GLP-1 agonists, such…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/117100
Author :
Publish date : 2025-08-21 15:45:00
Copyright for syndicated content belongs to the linked Source.
